- Home
- XERS vs HPK Comparison
XERS vs HPK Comparison
Compare XERS & HPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XERS | HPK |
|---|---|---|
| Founded | 2005 | 2019 |
| Country | United States | United States |
| Employees | N/A | 50 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 991.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | XERS | HPK |
|---|---|---|
| Price | $6.19 | $6.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $10.83 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.6M | 788.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | ★ 100.00 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $49,590,000.00 | N/A |
| Revenue This Year | $34.37 | N/A |
| Revenue Next Year | $22.86 | N/A |
| P/E Ratio | $623.50 | ★ $13.73 |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $4.30 | $3.85 |
| 52 Week High | $10.08 | $12.00 |
Technical Indicators
Market Signals| Indicator | XERS | HPK |
|---|---|---|
| Relative Strength Index (RSI) | 49.90 | 49.65 |
| Support Level | $5.81 | $6.74 |
| Resistance Level | $6.41 | $7.26 |
| Average True Range (ATR) | 0.31 | 0.60 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 30.21 | 53.13 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
About HPK HighPeak Energy Inc.
HighPeak Energy Inc is an independent crude oil and natural gas exploration and production company that explores for, develops and produces crude oil, NGL, and natural gas prominently in Howard County of the Midland Basin. The company operates in a single segment, which is crude oil and natural gas development, exploration, and production in the U.S. The majority of the company's revenue is derived from the Crude oil sales.